首页> 外文OA文献 >Scientific Opinion on a request from the European Commission for the assessment of the scientific elements put forward by Luxembourg to support the prohibition for the placing on the market of GM potato EH92-527-1 for cultivation purposes in Luxembourg
【2h】

Scientific Opinion on a request from the European Commission for the assessment of the scientific elements put forward by Luxembourg to support the prohibition for the placing on the market of GM potato EH92-527-1 for cultivation purposes in Luxembourg

机译:关于欧洲委员会要求评估卢森堡的科学成分以支持禁止在卢森堡种植用于种植目的的转基因马铃薯EH92-527-1的科学意见

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Luxembourg notified to the European Commission its scientific arguments justifying the implementation of a national safeguard measure prohibiting the placing on the market of GM potato EH92-527-1 for cultivation purposes in Luxembourg, after which the European Commission asked the European Food Safety Authority (EFSA) to assess the scientific information supporting the prohibition. Having considered the information package provided by Luxembourg and all relevant scientific publications, the EFSA Panel on Genetically Modified Organisms (GMO Panel) concluded that: (i) no new data specific to the safety of the nptII gene have been provided; (ii) although bacterial DNA release and development of competence are expected to occur more efficiently in biofilms, the link between resistance in biofilms and cultivation/processing of GM potato EH92-527-1 was not established by Luxembourg, and the main barriers, limiting the transformation frequency of bacterial cells with transgenic plant DNA, remain; (iii) the risk posed by the formation of mosaic structures of aminoglycoside phosphotransferase genes could not be assessed without data documenting the existence of such structures among the existing gene variants, and such data were not provided; (iv) the knowledge gaps and uncertainties highlighted in the Luxembourgeois document and the therapeutic relevance of kanamycin and neomycin have already been considered in the previous EFSA opinion on antibiotic resistance marker genes, and no new information on the safety of nptII gene as present in the GM potato EH92-527-1 has been identified in the scientific literature that would cause the GMO Panel to change its previous conclusions. Therefore, the EFSA GMO Panel concludes that no grounds exist to date that would lead to reconsideration of its opinion on GM potato EH92-527-1.
机译:卢森堡向欧盟委员会通报了其科学论据,证明有必要实施一项国家保障措施,禁止在卢森堡将转基因马铃薯EH92-527-1投放市场用于耕种,此后,欧盟委员会要求欧洲食品安全局(EFSA) )评估支持该禁令的科学信息。在考虑了卢森堡和所有相关科学出版物提供的资料后,欧洲食品安全局转基因生物专家组(GMO专家组)得出以下结论:(i)没有提供有关nptII基因安全性的新数据; (ii)尽管预计细菌膜中的DNA释放和能力发展将在生物膜中更有效地发生,但卢森堡尚未确定生物膜中的抗性与转基因马铃薯EH92-527-1的栽培/加工之间的联系,而主要障碍是限制保持转基因植物DNA对细菌细胞的转化频率; (iii)如果没有数据证明现有基因变体中存在这种结构,就无法评估氨基糖苷磷酸转移酶基因镶嵌结构形成所带来的风险;而没有提供此类数据; (iv)先前的EFSA关于抗生素抗性标记基因的意见已经考虑了Luxembourgeois文件中强调的知识差距和不确定性以及卡那霉素和新霉素的治疗意义,并且尚无关于nptII基因安全性的新信息。在科学文献中已经确定了转基因马铃薯EH92-527-1,这将导致GMO小组改变其先前的结论。因此,欧洲食品安全局(EFSA)GMO小组得出结论,迄今为止,尚无任何理由可以重新考虑其对转基因马铃薯EH92-527-1的意见。

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号